GUADAGNI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 9.734
AS - Asia 6.923
EU - Europa 1.394
SA - Sud America 628
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 144
OC - Oceania 17
Totale 19.022
Nazione #
US - Stati Uniti d'America 8.641
TR - Turchia 2.410
SG - Singapore 1.802
CN - Cina 1.679
CA - Canada 1.011
IT - Italia 659
BR - Brasile 491
VN - Vietnam 385
EU - Europa 177
HK - Hong Kong 162
IN - India 131
FR - Francia 125
DE - Germania 100
IE - Irlanda 99
GB - Regno Unito 86
BD - Bangladesh 57
MX - Messico 52
AR - Argentina 49
FI - Finlandia 48
PK - Pakistan 46
ZA - Sudafrica 44
RU - Federazione Russa 42
PL - Polonia 39
ID - Indonesia 36
ES - Italia 33
IQ - Iraq 33
JP - Giappone 31
SC - Seychelles 30
IL - Israele 29
NL - Olanda 26
UA - Ucraina 26
PH - Filippine 20
MA - Marocco 19
EC - Ecuador 18
RO - Romania 18
SA - Arabia Saudita 18
SE - Svezia 17
CO - Colombia 16
CL - Cile 15
LT - Lituania 14
AU - Australia 13
TN - Tunisia 12
PY - Paraguay 11
VE - Venezuela 11
UZ - Uzbekistan 10
EG - Egitto 8
KE - Kenya 8
KR - Corea 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DK - Danimarca 6
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AL - Albania 5
BB - Barbados 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
PE - Perù 5
TH - Thailandia 5
CH - Svizzera 4
GR - Grecia 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KW - Kuwait 2
MU - Mauritius 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SV - El Salvador 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 18.997
Città #
Kocaeli 2.103
San Mateo 1.619
Dallas 1.191
San Jose 1.138
Toronto 960
Ashburn 708
Beijing 482
Wilmington 464
Singapore 463
Houston 426
Rome 392
Santa Clara 390
Lawrence 322
Princeton 322
Chandler 210
Hong Kong 149
Ho Chi Minh City 139
Seattle 132
Fairfield 129
Los Angeles 115
Shanghai 101
Woodbridge 101
Hanoi 88
Guangzhou 67
Cambridge 55
São Paulo 47
Brooklyn 41
Helsinki 37
Dublin 36
New York 36
Shenzhen 33
Redwood City 31
Islamabad 30
Chicago 27
Frankfurt am Main 27
Mexico City 27
Netanya 27
Tokyo 27
Warsaw 27
The Dalles 26
Johannesburg 24
Chennai 22
Orem 22
Columbus 21
Da Nang 20
London 19
Boston 17
Council Bluffs 17
Montreal 17
Munich 17
Saint Petersburg 17
Haiphong 16
Milan 16
Wuhan 16
Baghdad 15
Quanzhou 15
Redmond 15
Rio de Janeiro 15
Xi'an 14
Jiaxing 13
Mumbai 13
Washington 13
Amsterdam 12
Phoenix 12
Rui'an 12
Ankara 11
Atlanta 11
Belo Horizonte 11
Buffalo 11
Nanjing 11
Pune 11
Roubaix 11
Wuxi 11
Bandung 10
Curitiba 10
Kyiv 10
San Francisco 10
Stockholm 10
Hyderabad 9
Pesaro 9
Tashkent 9
Thái Nguyên 9
Turku 9
Bari 8
Bexley 8
Dhaka 8
Dongyang 8
Jinhua 8
Philadelphia 8
Riyadh 8
Taizhou 8
Wroclaw 8
Biên Hòa 7
Jakarta 7
Nantong 7
Vicenza 7
Xuzhou 7
Zhengzhou 7
Asunción 6
Brescia 6
Totale 13.464
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 139
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 133
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 125
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 120
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 119
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 107
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 106
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 105
Activation of blood coagulation in breast cancer - relationship to clinical outcome 103
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 99
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 98
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 98
Aging: an important risk factor in chemotherapy-associated vascular diseases 98
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 93
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 92
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 92
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 91
A NOVEL NONSENSE MUTATION IN KRAS GENE 91
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 89
A Simple and Effective Method to Analyze Membrane Proteins by SDS-PAGE and MALDI Mass Spectrometry 88
An AT-Rich Region in the APC Gene May Cause Misinterpretation of Familial Adenomatous Polyposis Molecular Screening 88
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 87
Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection 86
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 85
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 84
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 83
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 79
Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression 79
Age-related reduction of cerebral ischemic preconditioning: myth or reality? 79
"Proteomineering" or not? The debate on biomarker discovery in sera continues 77
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 77
“Personal and sensitive data in the e-health-IoT universe” 76
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 75
Sentinel lymphadenectomy in cutaneous melanoma 74
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 74
MAINTENANCE OF EXPRESSION OF TUMOR-ANTIGENS IN 3-DIMENSIONAL INVITRO HUMAN TUMOR GEL-SUPPORTED HISTOCULTURE 74
Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer 74
BRCA1 and BRCA2 mutations in central and southern Italian patients 73
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers 73
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 72
Role of interleukin-6 in the diagnosis of acute aortic dissection 72
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 72
VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients 72
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 71
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 71
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 71
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 70
Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs 70
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 69
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation 69
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 69
Protective Effect of Antioxidants in Nitric Oxide/COX-2 Interaction during Inflammatory Pain: The Role of Nitration 69
Tumor markers as targets for selective diagnostic and therapeutic procedures 68
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab 68
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 68
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 68
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 67
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 67
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 67
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 67
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 67
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 67
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 67
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 67
Machine learning approach to predict medication overuse in migraine patients 67
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 66
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 66
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 66
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 66
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 66
CA-72-4 MEASUREMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72) AS A SERUM MARKER IN THE MANAGEMENT OF GASTRIC-CARCINOMA 66
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 66
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients 66
Artificial intelligence for cancer-associated thrombosis risk assessment 66
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 65
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 65
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 65
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 65
Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters 65
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 65
Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing 65
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 65
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 65
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 64
Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia 64
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 64
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 64
Plasma von Willebrand factor antigen levels in non-small cell lung cancer patients 64
Effect of acute consumption of oolong tea on antioxidant parameters in healthy individuals 64
CA-72-4 SERUM MARKER - A NEW TOOL IN THE MANAGEMENT OF CARCINOMA PATIENTS 64
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 64
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 64
Is CEA serum measurement useful in monitoring breast cancer patients? 63
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 63
Determinants of platelet activation in pulmonary arterial hypertension 63
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 63
Early diagnosis of hepatocellular carcinoma in cirrhotic patients: Evaluation of new biologic markers 63
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 63
Genetic instability in superficial bladder cancer and adjacent mucosa: An interphase cytogenetic study 63
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 63
Totale 7.634
Categoria #
all - tutte 180.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 0 0 0 0 0 0 230
2021/20223.140 19 961 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.898 158 642 144 110 162 499 197 145 325 20 80 416
2025/20267.121 534 751 922 475 517 835 1.069 438 585 829 97 69
Totale 19.490